Sign Up
Stories
Sensorion's Annual General Meeting Results
Share
AudioCure Pharma's Hearing Technology In...
BioSenic's Progress and Patent
Biotech Advancements in Hearing Loss Tre...
Sensorion Showcases SENS-501 Therapy
Overview
API
Sensorion announces positive results of resolutions presented at its Annual General Meeting. Shareholders approve recommended resolutions. The company focuses on developing innovative therapies for hearing loss.
Ask a question
How does Sensorion's collaboration with Institut Pasteur contribute to their gene therapy and gene editing efforts?
What are the potential implications of Sensorion's focus on small molecules for treatment and prevention of hearing loss?
What are the specific resolutions that were approved by shareholders?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Coverage